Back
Sarepta Therapeutics, Inc. Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison
Sell
44
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$22.33
Seasonality Move:
6.08%
Buy
52
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$60.16
Seasonality Move:
5.6%
Sell
44
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $22.32. The Score for SRPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
BioMarin Pharmaceutical, Inc. (BMRN)
is a Buy
Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $60.16. The Score for BMRN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $22.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMRN Stock Price Chart
What is BioMarin Pharmaceutical, Inc.'s stock price today?
-
The BioMarin Pharmaceutical, Inc. share price today is $60.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.69 | Buy |
| Relative Strength Index (14 RSI): | 57.4 | Buy |
| Chaikin Money Flow: | 705480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.05 - 22.53) | Buy |
| Bollinger Bands (100): | (17.77 - 22.29) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.3 | Buy |
| Relative Strength Index (14 RSI): | 65.19 | Buy |
| Chaikin Money Flow: | -617307 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.02 - 57.56) | Buy |
| Bollinger Bands (100): | (52.63 - 57.55) | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.49 | Buy |
| 20-day SMA: | 21.54 | Buy |
| 50-day SMA: | 20.78 | Buy |
| 200-day SMA: | 30.87 | Sell |
| 8-day EMA: | 16.81 | Buy |
| 20-day EMA: | 9.68 | Buy |
| 50-day EMA: | 4.56 | Buy |
| 200-day EMA: | 1.24 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.17 | Buy |
| 20-day SMA: | 54.92 | Buy |
| 50-day SMA: | 54.08 | Buy |
| 200-day SMA: | 57.77 | Buy |
| 8-day EMA: | 57.52 | Buy |
| 20-day EMA: | 55.6 | Buy |
| 50-day EMA: | 54.79 | Buy |
| 200-day EMA: | 58.34 | Buy |
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.
BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.74 per share.
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioMarin Pharmaceutical, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||